# Propranolol for the Treatment of Kaposi Sarcoma in Adults

> **NCT06445166** · PHASE2 · RECRUITING · sponsor: **Washington University School of Medicine** · enrollment: 25 (estimated)

## Conditions studied

- Kaposi Sarcoma

## Interventions

- **DRUG:** Propranolol Hydrochloride

## Key facts

- **NCT ID:** NCT06445166
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-20
- **Primary completion:** 2028-02-01
- **Final completion:** 2028-08-01
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2026-04-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06445166

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06445166, "Propranolol for the Treatment of Kaposi Sarcoma in Adults". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06445166. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*